HLA Typing Market to be driven by growing incidence of chronic diseases and rising demand for organ transplantation are expected to grow at a CAGR of 6.00% during the forecast period 2024 to 2032

Market Research Future (MRFR) has published a cooked research report on the “Global HLA Typing Market” that contains information from 2019 to 2032. The HLA Typing market is estimated to register a CAGR of 6.00% during the forecast period of 2024 to 2032.

Market Highlights

The global HLA Typing market is accounted to register a CAGR of 6.00% during the forecast period and is estimated to reach USD 2.5 billion by 2032.

The demand for HLA typing to reduce the risk of transplant rejection has increased due to the rising global burden of chronic diseases, including acute and chronic hepatitis, coronary artery disease, end-stage renal disease, chronic kidney disease, and chronic renal disease among people of all ages. High-throughput simultaneous screening of numerous genes is made possible by next-generation sequencing (NGS) technologies, which also dramatically lower consumable costs. HLA typing integration in the field of customized immunotherapy is anticipated to be a significant advancement.

Key Players

MRFR recognizes the following companies as the key players in the global HLA Typing market— Bio-Rad Laboratories, Inc. (US), F Hoffmann-La Roche Ltd (Switzerland), QIAGEN V (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMérieux SA (France).

Segment Analysis

The global HLA Typing market has been segmented based on Technology, Product & Service, Application and End-user.

On the basis of technology, the market is segmented into Molecular Assay Technologies and Non-molecular Assay Technologies. The molecular assay technologies segment was attributed to holding the largest market share in 2023. The reason molecular tests are useful for identifying infectious disorders is because they have a high sensitivity and specificity.

On the basis of product & Service, the market is segmented into Reagents & Consumables, Instruments, and Software & Services. The Instruments segment was attributed to holding the largest market share in 2023. This is a result of their growing utility and affordability.

Based on application, the global HLA Typing market has been segmented into Diagnostic Applications, Research Applications, Donor-recipient cross-matching, Infectious disease testing, Cancer diagnosis & prevention, Transfusion therapy, and other diagnostic applications. The Diagnostic Applications segment was expected to hold the largest market share in 2023. This is due to the increasing prevalence of using HLA typing in the diagnosis of rare and chronic illnesses.

Based on end-user, the global HLA Typing market has been segmented into Commercial service providers, Hospitals & surgical centers and Research laboratories & academic institutes. The Hospitals & surgical centers segment was expected to hold the largest market share in 2023. This is a result of both the growing patient base and the increasing number of transplant procedures performed in hospitals.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of HLA Typing Market Research Report

Regional Analysis

The global HLA Typing market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe HLA Typing market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The HLA Typing market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World HLA Typing market comprises the Middle East, Africa, and Latin America.

The largest market share for HLA Typing was maintained by the North American regional sector. This is because North America, which accounted for a portion of sales, is anticipated to see a significant revenue increase during the course of the forecast. Growth can be attributed to a number of factors, including rising investment in HLA research, a rise in the prevalence of chronic diseases, the existence of a developed healthcare system and modern healthcare infrastructure, the quick adoption of cutting-edge transplant technologies, an increase in the number of organ transplant procedures performed, and the strong presence of important players in the area. Furthermore, there is swift progress in technology in transplant diagnosis and the growing prevalence of medical devices.

Moreover, the Europe market has been persistently growing over the forecast period. The demand Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), two technological developments in HLA typing techniques, have increased the efficiency, speed, and accuracy of HLA typing testing. Market expansion is fueled by the use of these cutting-edge technologies in European laboratories.

Additionally, because of the improved infrastructure of healthcare facilities, thoughtfully crafted reimbursement policies and the rising growth of economic elements that have a favorable impact on the industry, Asia Pacific is predicted to have the quickest growth in the human leukocyte antigen matching market. Modern labs with cutting-edge technology will propel the market along with the growing number of transplant hospitals and qualified personnel.

Furthermore, the rest of the world's HLA Typing market is divided into the Middle East, Africa, and Latin America. The growth is due to the rising global burden of chronic diseases, including acute and chronic hepatitis. Government support, a rise in investor interest, and the viability of the technology in the sector are all contributing factors to the market expansion.

Key Findings of the Study

• The global HLA Typing market is expected to reach USD 5 billion by 2032, at a CAGR of 6.00% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market because of the improved infrastructure of healthcare facilities, thoughtfully crafted reimbursement policies, and the rising growth of economic elements that have a favorable impact on the industry.


• Based on application, Diagnostic Applications segment was expected to hold the largest market share in 2023.


• Bio-Rad Laboratories, Inc (US), F Hoffmann-La Roche Ltd (Switzerland), QIAGEN V (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMérieux SA (France) are the key market players.